BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16139566)

  • 1. MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
    Friese MA; Jones EY; Fugger L
    Trends Immunol; 2005 Nov; 26(11):559-61. PubMed ID: 16139566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
    Swanberg M; Lidman O; Padyukov L; Eriksson P; Akesson E; Jagodic M; Lobell A; Khademi M; Börjesson O; Lindgren CM; Lundman P; Brookes AJ; Kere J; Luthman H; Alfredsson L; Hillert J; Klareskog L; Hamsten A; Piehl F; Olsson T
    Nat Genet; 2005 May; 37(5):486-94. PubMed ID: 15821736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.
    Akkad DA; Jagiello P; Szyld P; Goedde R; Wieczorek S; Gross WL; Epplen JT
    Int J Immunogenet; 2006 Feb; 33(1):59-61. PubMed ID: 16426246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus.
    Linga-Reddy MV; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Nordmark G; Rönnblom L; Alarcón-Riquelme ME
    Tissue Antigens; 2007 Nov; 70(5):412-4. PubMed ID: 17711409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the MHC2TA gene in autoimmune diseases.
    Martínez A; Sánchez-Lopez M; Varadé J; Mas A; Martín MC; de Las Heras V; Arroyo R; Mendoza JL; Díaz-Rubio M; Fernández-Gutiérrez B; de la Concha EG; Urcelay E
    Ann Rheum Dis; 2007 Mar; 66(3):325-9. PubMed ID: 17012290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
    Shi B; Vinyals A; Alia P; Broceño C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A
    Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of gene regions regulating inflammatory microglial response in the rat CNS after nerve injury.
    Diez M; Abdelmagid N; Harnesk K; Ström M; Lidman O; Swanberg M; Lindblom R; Al-Nimer F; Jagodic M; Olsson T; Piehl F
    J Neuroimmunol; 2009 Jul; 212(1-2):82-92. PubMed ID: 19525015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE; Yu HN; Yoon CH; Bae YS
    Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
    Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
    Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
    Mumtaz M; Löfgren S; Hugander A; Dimberg J
    Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta.
    Harnesk K; Swanberg M; Diez M; Olsson T; Piehl F; Lidman O
    J Neuroimmunol; 2009 Jul; 212(1-2):44-52. PubMed ID: 19481818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
    Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W
    Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Misfolded proteins complexed with HLA class II molecules are involved in autoimmune diseases as a target for autoantibodies].
    Arase N; Arase H
    Nihon Rinsho; 2016 Feb; 74(2):359-68. PubMed ID: 26915265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M; Jager M; Ono SJ
    Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning, distribution and up-regulation of the teleost fish MHC class II alpha suggests a role for granulocytes as antigen-presenting cells.
    Cuesta A; Angeles Esteban M; Meseguer J
    Mol Immunol; 2006 Mar; 43(8):1275-85. PubMed ID: 16168483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.